FolioLanternBeta
PAHCPhibro Animal Health Corp · Insider ownership research

Phibro Animal Health Corp insiders sold $30.0M in the past 12 months. How much of their stake is that?

100% was sold under disclosed trading plans. The largest seller, Jack Bendheim (Executive Chairman, Director), sold $30.0M.Share-of-stake figures for this company are being verified and will be added when that check is finished. Why

Updated Oct 16, 2026 from SEC filings · covers Oct 17, 2025 to Oct 16, 2026
1
buyer among officers and directors (1 trade), past 12 months
100%
of sales were under disclosed trading plans, past 12 months
1 of 10
officers and directors sold shares, past 12 months
Is this normal? More than usual: $30.0M sold, after almost none in the past 5 years. 1 insider sold; the average is 0 a year. Year by year
Latest filing: Filed Sep 17 for a stock award on Aug 6. Larry Miller received an award of 3.7K shares. Filing
SEC ownership filings: 53 filed in the 12 months to Oct 16, 2026; 334 on record since Apr 10, 2014 · See the evidence

What stands out

Thomas Corcoran bought 10K shares for $318K, first on May 29, 2026.Purchase, May 29, 2026

A share of stake is shown for 0 of the 1 officer or director who sold. 10 are left out

i
Left out: Jack Bendheim, Larry Miller, Glenn David, Thomas Corcoran, Daniel Bendheim, Judith Weinstein, Jonathan BENDHEIM, Lisa Escudero, Anthony Andolino and Patrick Rodriguez (share of stake is being verified).
Disclosed company stock is not an insider's whole wealth.

Who sold, and how much of their stake

Officers and directors, past 12 months. Their share of stake is being verified and is not shown yet; amounts and trading plans are below.

Jack Bendheim
Executive Chairman, Director
Not confirmed
Share of stake not shown: share of stake is being verified. Why
$30.0MDisclosed plan
Amounts, filings and trading plans for each seller

Selling by month

Officers and directors, Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planOne dollar scale for every month; the tallest bar is labeled
Oct 2025: $1.9M under a disclosed planOctNov 2025: $4.9M under a disclosed planNovDec 2025: $863K under a disclosed planDecJan 2026: $2.3M under a disclosed planJanFeb 2026: $12.2M under a disclosed plan$12.2MFebMar 2026: $3.4M under a disclosed planMarApr 2026: $3.5M under a disclosed planAprMay 2026: $1.0M under a disclosed planMayJunJulAugSepOct

Recent activity

Past 30 days, Sep 17, 2026 to Oct 16, 2026

No officer or director trades were reported for the past 30 days. The most recent before that:

May 29, 2026Thomas Corcoran bought 10K shares ($318K).
WhoSharesPrice% of total stakeTotal stake afterTrade dateFiled
Thomas Corcoran
Director
10,000$31.77n/an/aMay 29, 2026Jun 2, 2026

Common questions

Is the Phibro Animal Health Corp CEO selling stock?

No. Daniel Bendheim reported no open-market sales in the past 12 months.

Why are Phibro Animal Health Corp insiders selling?

Filings rarely give a reason, and we don't guess at one. What they show is how the sales were made: 100% of sales by value ran under 10b5-1 trading plans disclosed in the filings. A trading plan schedules sales in advance.

Are any Phibro Animal Health Corp insiders buying?

Yes. 1 officer or director reported 1 purchase in the past 12 months (Form 4 code P; rows the filings describe as reinvested dividends, plan purchases, private deals or moves into the person's own trust are not counted).

The evidence

Who sold1 officer or director: amount, % of holdings, trading plan
Who soldAmount% of holdingsTrading plan
Jack Bendheim
Executive Chairman, Director
$30.0M
625K shares
Not confirmed
share of stake is being verified. Why
Disclosed plan
The full ownership picture0 of 10 officers and directors confirmed

Vested shares across all share classes, held directly and through trusts, LLCs and family members, as reported on SEC Forms 3, 4 and 5. Unvested awards and options are never counted as owned shares.

InsiderHeld Oct 16, 2025SoldHeld Oct 16, 2026Still held
Jack Bendheim
!
Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Jack Bendheim are complete.
Executive Chairman, Director
n/a−625Kn/an/a
Vesting, gifts, unvested awards and holding lines for Jack Bendheim

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Jack Bendheim are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)
Larry Miller
!
Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Larry Miller are complete.
Chief Operating Officer
n/a0n/an/a
Vesting, gifts, unvested awards and holding lines for Larry Miller

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Larry Miller are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)
Glenn David
!
Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Glenn David are complete.
Chief Financial Officer
n/a0n/an/a
Vesting, gifts, unvested awards and holding lines for Glenn David

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Glenn David are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)
Thomas Corcoran
!
Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Thomas Corcoran are complete.
Director
n/a0n/an/a
Vesting, gifts, unvested awards and holding lines for Thomas Corcoran

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Thomas Corcoran are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)
Daniel Bendheim
!
Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Daniel Bendheim are complete.
President and CEO, Director
n/a0n/an/a
Vesting, gifts, unvested awards and holding lines for Daniel Bendheim

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Daniel Bendheim are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)
Judith Weinstein
!
Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Judith Weinstein are complete.
Senior Vice President, General Counsel and Corporate Secretary
n/a0n/an/a
Vesting, gifts, unvested awards and holding lines for Judith Weinstein

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Judith Weinstein are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)
Jonathan BENDHEIM
!
Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Jonathan BENDHEIM are complete.
Director
n/a0n/an/a
Vesting, gifts, unvested awards and holding lines for Jonathan BENDHEIM

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Jonathan BENDHEIM are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)
Lisa Escudero
!
Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Lisa Escudero are complete.
Senior Vice President, Human Resources
n/a0n/an/a
Vesting, gifts, unvested awards and holding lines for Lisa Escudero

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Lisa Escudero are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)
Anthony Andolino
!
Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Anthony Andolino are complete.
Vice President Finance and Treasurer
n/a0n/an/a
Vesting, gifts, unvested awards and holding lines for Anthony Andolino

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Anthony Andolino are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)
Patrick Rodriguez
!
Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Patrick Rodriguez are complete.
VP Finance and Treasurer
n/a0n/an/a
Vesting, gifts, unvested awards and holding lines for Patrick Rodriguez

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Patrick Rodriguez are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Holdings and share of stake for Phibro Animal Health Corp are being verified, so no balances, unit counts or percentages are shown. Sales, proceeds, plan and tax status, titles and dates come straight from individual filings.

What explains the selling$30.0M of sales by plan status, purpose, seller and month

Officer and director open-market sales: $30.0M across 624,522 shares. Plan status and stated purpose are separate questions, and a sale can have both.

By plan status

Purchases · 1 buyer (1 trade)

1 officer or director bought shares in this period, in 1 trade(Form 4 code P, leaving out rows the filings describe as reinvested dividends, plan purchases, private deals or moves into the person's own trust). Across all their filings on record there are 7 purchase trades.

SellerShares soldProceedsUnder a disclosed planShare of totalSales dates
Jack Bendheim
Executive Chairman, Director
625K$30.0M100%100%Oct 17, 2025 to May 7, 2026

Sales by month

MonthSale proceedsDisclosed planTo cover taxesNo plan disclosed
Oct 2025$1.9M$1.9M$0$0
Nov 2025$4.9M$4.9M$0$0
Dec 2025$863K$863K$0$0
Jan 2026$2.3M$2.3M$0$0
Feb 2026$12.2M$12.2M$0$0
Mar 2026$3.4M$3.4M$0$0
Apr 2026$3.5M$3.5M$0$0
May 2026$1.0M$1.0M$0$0
Jun 2026$0$0$0$0
Jul 2026$0$0$0$0
Aug 2026$0$0$0$0
Sep 2026$0$0$0$0
Oct 2026$0$0$0$0
Is this normal? Selling year by year5 earlier years to compare with

More than usual: $30.0M sold, after almost none in the past 5 years. 1 insider sold; the average is 0 a year.

12 months endingShares soldInsiders who soldProceeds
Oct 16, 2026
Latest 12 months
625K1$30.0M
Oct 16, 2025
1 year earlier
49K1$2.0M
Oct 16, 2024
2 years earlier
00$0
Oct 17, 2023
3 years earlier
00$0
Oct 17, 2022
4 years earlier
00$0
Oct 17, 2021
5 years earlier
20K1$459K

Open-market sales (Form 4 code S) by people who were officers or directors, in split-adjusted shares. Earlier years include people who have since left. A sale that an outside holder also reports (a family trust, a fund) is counted with outside holders in every year. Shares, not dollars, are compared, so a change in the stock price doesn't look like a change in selling. Years the filings don't fully cover are shown but left out of the average.

Known gaps and uncertainty10 officers and directors not confirmed

Holdings and share of stake are being verified. Balances, unit counts and every share-of-stake figure for Phibro Animal Health Corp are held back until that check is finished. Sales, proceeds, plan and tax status, titles and dates come straight from individual filings and are complete.

External context: we only cite outside events when a documented connection exists. None is shown for this period.

Sources and methodology334 filings on record, 53 filed in the 12-month period, and how we read them

All 334 Forms 3, 4 and 5 on record for Phibro Animal Health Corp (SEC CIK 1069899), filed from Apr 10, 2014 to Sep 17, 2026; 53 of them were filed in the 12 months this page covers, retrieved from SEC EDGAR on Oct 16, 2026. Prices are the ones reported in each filing, often weighted averages.

Holdings. Each holding line (a share class plus an owner, such as a trust or LLC) carries its last reported balance forward. Entities first reported during the period start at zero, so transfers between an insider's own trusts don't count as selling. Lines not reported for three years or more are listed separately and left out of totals.

Sales. A sale counts as under a 10b5-1 plan if its footnote cites one or the filing's Rule 10b5-1 box is checked, and as tax-related if its footnote cites tax obligations or sell-to-cover. Shares withheld by the company for taxes are listed separately. Sales with neither attribute are labeled "no plan disclosed".

Full methodology

Former or inactive filers (15)No filing in 18 months; last reported balances, not in any total
NameLast filedLast reported balance
Dean WarrasJan 17, 2019No balance on record
Richard JohnsonSep 15, 2017No balance on record
Gerald CarlsonSep 12, 2017No balance on record
Thomas DaggerJun 5, 2017No balance on record
Daniel WelchMar 16, 2017No balance on record
Mayflower L.P.Jan 9, 20151,727,748 shares, last reported balance as of Jan 9, 2015
Carol WrennApr 16, 20141,000 shares, last reported balance as of Apr 16, 2014
David StorbeckNo balance on record
Sam GejdensonNo balance on record
Mary MalanoskiNo balance on record
Kenneth HanauNo balance on record
Robin AukermanNo balance on record
Damian FinioNo balance on record
Alejandro BernalNo balance on record
Joyce LeeNo balance on record

Spotted something wrong on this page? Report an error. We check every report against the SEC filing and list what we fix in the corrections log.